GEN inCode Announces Major UK Collaboration With Royal Brompton and Harefield Hospitals
GEN inCode Announces Major UK Collaboration With Royal Brompton and Harefield Hospitals USA - English Share this article Share this article OXFORD, England, April 28, 2021 /PRNewswire/ -- GEN inCode UK Limited, the cardiovascular disease company focused on predictive genetics for the prevention of cardiovascular disease, announces today a collaboration with Royal Brompton and Harefield hospitals ("RB&H"), recently merged with Guy's and St Thomas' NHS Foundation Trust ("GSTT"), to provide globally leading cardiovascular disease clinical genetic testing and reporting. GEN inCode specializes i...
Source: prnewswire.com